|
MedNest is the first Contract Operations Organization in the US dedicated to Medical Technologies
Our Mission
MedNest sources and develops the business of innovative Medical Technology companies for the US markets, exclusively in the Drug – Devices and Diagnostic – Healthcare IT and Services convergence space, to accelerate disruptive changes in the US Healthcare System.
Our Services
MedNest offers contract Business and Clinical Operations services to companies looking for an experienced partner to operate their organic or inorganic growth projects, in particular during transition times (ex: US market access, deal search or post-acquisition integration), when execution risks and time to market must be minimal.
Our Team
The MedNest team players are all highly experienced and senior healthcare leaders. They execute your projects and deliver on the objectives and deliverables that were committed to you.
|
07/21: MedNest welcomes Echosens as a new client. Echosens is a high-technology medical company specializing in non-invasive diagnostics in Hepatology.
07/20: MedNest welcomes Beep N Track as a new client. Beep N Track offers end-to-end RFID traceability solutions for implantable medical devices, from Device manufacturer to patient.
06/28: MedNest welcomes EBC Medical as a new client. EBC Medical is a European Leader in the design and commercialization of Opthalmic and Eye care solutions.
06/21: MedNest congratulates LLTech for the first US-in-country delivery and installation of the Light-CT, a fully 2D-3D digital sub-micron pathology imaging system.
06/21: MedNest welcomes Voluntis as a recurring client. Voluntis provides electronic patient relationship management solutions to enhance Chronic Care and Disease Management
06/14-18: 10 eHEALTH companies join MedNest to meet with US industry leaders and scan the US ecosystems for business opportunities (see MedNest's eHEALTH CEO Forum)
05/10 MedNest joins the Office of the Dean of Research of Princeton University, the NJ Economic Development Agency, and a select group of CEOs to welcome a Delegation of the Directorate-General for Life-Sciences Research of the European Commission.
05/3 MedNest partners with New Zealand Trade and Enterprise and sponsors the "Focus on Health Business Development Challenge". This Program aims to introduce some of New Zealand?s most innovative and commercially viable health solutions into the US healthcare system
04/30 MedNest presents "Best Practices to Enter the US MedTech Markets" to a panel of entrepreneurs in Montpelier, France
04/23 MedNest sponsors and participates to the International Life Sciences Workforce Summit, Princeton University (program)
03/3 MedNest welcomes the Chamber of Commerce of Bordeaux and the Aquitaine region as repeat client to launch the 2010 e-HEALTH US Market Development CEO Program for 10 selected mid-size companies ready to pan adn execute their US market entry.
03/12 MedNest welcomes Fluofarma (France) as a new client. Fluofarma is a privately-held contract service provider which offers High Content Screening (HCS) services for target and drug discovery, predictive toxicity testing and cosmetics development.
03/8 MedNest's CEO program is recognized by the International Trade Department of the State of New Jersey (article)
03/3 MedNest meets several Israeli e-HEALTH entrepreneurs at HIMSS2010 ( Atlanta) and secures several partnership intents for its existing clients.
02/10 MedNest joins the German American Chamber of Commerce to help bridge Innovative Medical Technology Companies to the US markets.
01/20 MedNest welcomes TEM SEGA as a new client. TEM Sega is investigating the opportunity to launch a innovative Cystic Fibrosis Sweat Test in the US markets..
01/12 MedNest welcomes Creapharm Europe (France) as a returning client. Créapharm is the leading Investigational Medicinal Products supplier in France and is seeking for strategic partners in the US to grow.
Many Warm Wishes for a Joyous Holiday Season and a Prosperous New Year!
12/16 MedNest welcomes Image Guided Therapies (IGT, France) as a new client. IGT is a medical device company active in the field of MR guided focused ultrasound and minimally invasive thermal ablations, exploring innovative Image Guided Targeted Drug Delivery solutions with MedNest.
12/15 New Jobs available for MedNest clients
12/15 MedNest welcomes ABOdiag (France) as a new client. ABODiag provides innovative Blood Diagnostic Devices.
11/19 MedNest congratulates Nexus6 of NZ for the 510k of its SmartTrack device
11/19 MedNest congratulates Activ'Sante for the launch of Activ Doctor Consult in Florida
11/10 BioSpine S14 and MedNest meet Key Opinion Leaders at the North American Spin Society Annual Meeting in San Franciso
11/9 AXS Ingenierie and MedNest present at the Orthopedic Investment Conference in San Francisco.
10/15 MedNest presents 2009 success stories at the NJ Consul Event Program
10/11 MedNest congratulates AXS Ingenierie for its first US Patients imaged on BIOMOD
10/5 MedNest participates to the Cleveland Clinic Medical Innovation Summit (web)
09/21 MedNest welcomes BioSpine (France) as a new customer. BioSpine designs innovative implants to treat degenerative spinal pathologies as well as deformities of the spine, with new concepts of dynamic stabilization (web)
08/29 MedNest welcomes Microtransponder Inc (USA) as a new customer. Microtransponder Inc is developing a wireless neurostimulation system for the treatment of chronic pain (web)
08/26 VCs are bullish about Convergent Technologies (WSJ Article)
08/23 MedNest receives final US Trademark notification: Welcome to MedNestTM
08/21 MedNest welcomes two new Associate Members, Paul Soskey, Ph.D and Richard Wildnauer, Ph.D, MBA (see Team)
08/18 After successfully raising funds, AXE Ingenierie (France) renews and expands collaboration with MedNest in the area of 3D visualization of spine deformities (abstract)
07/15 Entrepreneurs from Bordeaux Look to New Jersey for US Location (Article)
07/15 NEXUS6 (New Zealand) renews and expands collaboration with MedNest in the area of remote compliance monitoring for respiratory chronic diseases (Asthma, COPD).
06/25 Rutgers, N.J. Seeks to develop MedTech connection with France and highligths MedNest role as a catalyst (Article)
06/11 With BioNJ, MedNest announces its MedTech Ventures and Partnership Summit in Princeton, June 23rd
06/03 MedNest 's CIO Ken Accardi explains Electronic Medical records (Article):
06/08 MedNest welcomes Activ'Sante, France, as a new customer. Activ'Sante provides Medical Second Opinion services leveraging the emerging global EMR networks and infrastructures (web).
05/29 MedNest joins the Mass Technology Leadership Council, Boston, MA
05/15 MedNest welcomes Nexus6 as a repeat customer. Nexus6's Smartinhaler provides remote and realtime compliance monitoring of respiratory chronic diseases.
04/28 MedNest triggers interest at "Investments In Innovation" in Paris when presenting "Nonatec Medical" to an audience of MedTech CEOs and Investors.
04/23 MedNest welcomes the Chamber of Commerce of Bordeaux and 10 CEOs of local MedTech companies as new clients.
04/06 MedNest participates to HIMMS 2009 and receives great feedback on its portfolio of Convergent Medical Technology products.
04/06 MedNest announces new Medical Software Validation Services (announcement)
04/02 MedNest welcomes LLTech, France, as a new client. LLTech provides cellular resolution imaging devices, enabling non invasive, non destructive optical biopsies.(web site).
|
|